Clinical Trial Update: A Placebo-Controlled Study to Investigate the Onset of Action of Paroxetine in Premenstrual Dysphoria [Phase 4]

View source ↗

Summary

A Phase 4 placebo-controlled trial evaluated the onset of action of paroxetine for Premenstrual Dysphoric Disorder and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premenstrual Dysphoric Disorder
• Premenstrual Syndrome

Drugs mentioned

• Paroxetine (Paroxetine hydrochloride)

Snippet

Sponsor: Karolinska Institutet | Conditions: Premenstrual Dysphoric Disorder, Premenstrual Syndrome | Phase 4 | Status: COMPLETED